Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Corporate News Release

Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial

05/10/07

-- conference call and audio web cast on October 9, 2007 --

BELLEVILLE, ON, Oct. 5 /CNW/ - Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company (TSX:BNC), will be discussing the U.S. Department of Agriculture (USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine during a:

Conference Call & Audio Web Cast
Tuesday, October 9, 2007
9:00 a.m. (Eastern)

To participate in the teleconference, call 416-644-3414/toll-free 1-800-733-7571.

A listen-only audio web cast will be available at:

English

French

A replay of the conference call will be available until October 16, 2007 by calling (416) 640-1917 or toll-free 1-877-289-8525 (passcode: 21249516 followed by the number sign).

The web cast will be available for replay using the above links until January 9, 2008.

###


Back

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Food Safety
Human Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy